Catalyst Pharmaceuticals, Inc.
Price Action
Technical Summary
CONSOLIDATINGCatalyst Pharmaceuticals, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 52), indicating performance broadly in line with the market. Earnings contraction of 9% provides fundamental context to the price action. Volume support will be critical for the stock to resolve this consolidation to the upside.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $24.37 | -5.28% | BELOW |
| 50 SMA | $23.87 | -3.33% | BELOW |
| 100 SMA | $22.97 | +0.49% | ABOVE |
| 150 SMA | $22.09 | +4.48% | ABOVE |
| 200 SMA | $22.32 | +3.41% | ABOVE |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is CPRX in an uptrend right now?
CPRX has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is CPRX overbought or oversold?
CPRX's RSI (14) is 58. The stock is in neutral territory, neither overbought nor oversold.
Is CPRX outperforming the market?
CPRX has a Relative Strength (RS) Rating of 52 out of 99. CPRX is performing about average compared to the market.
Where is CPRX in its 52-week range?
CPRX is trading at $23.08, which is 87% of its 52-week high ($26.58) and 54% above its 52-week low ($19.05).
How volatile is CPRX?
CPRX has a Beta of 0.82 and 52-week volatility of 35%. It's less volatile than the S&P 500 - generally more stable.